| Literature DB >> 11826480 |
N Honoré1, P W Roche, J H Grosset, S T Cole.
Abstract
A genotypic method for predicting rifampicin resistance in Mycobacterium leprae has been developed and rigorously tested on mouse footpad-derived and clinical specimens. A series of immobilized oligonucleotide capture probes can discriminate between wild type and mutant rpoB alleles, and positive controls are available for the most frequent mutation affecting Ser425. Two different non-radioactive detection formats have been tested with comparable success in both an industrialized and a developing country. The standardized procedure could now be used in a prospective study of potential rifampicin resistance among multibacillary patients.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11826480 DOI: 10.5935/0305-7518.20010052
Source DB: PubMed Journal: Lepr Rev ISSN: 0305-7518 Impact factor: 0.537